first generic glp 1 GLP-1 Injection to Treat Type 2 Diabetes is Approved by FDA GLP-1 Drug Overdose

To confirm whether the reduction in heat sensitivity after glucose application was due to the systemic release of GLP-1, we intraperitoneally administered 10 g/kg GLP-1(736), one of the two primary biologically active forms of secreted GLP-1

there were fewer injection-site reactions with dulaglutide and subcutaneous semaglutide once weekly (35,43), and also with liraglutide once daily (38), compared with exenatide once weekly

[21] examined human tissues including normal and cancerous tissues and found that normal human thyroid tissue from non-neoplastic and neoplastic thyroid glands did not express GLP-1R (0/6, 0%)

Explaining why GLP-1 drugs improve health without weight loss defies simple narratives and confounds researchers